Risk Factors of Very Severe RSV Infections in a Multicenter Cohort of Very Preterm and Extreme Preterm Babies Receiving or Not Palivizumab
IntroductionPreterm infants are at risk of lower respiratory tract infections (LRTI), including Respiratory Syncytial Virus (RSV) associated bronchiolitis, for which palivizumab prophylaxis can be proposed. Our aim was to determine risk factors of very severe RSV disease in children born before 34 w...
Saved in:
Main Authors: | Gwenaelle Mulot (Author), Mehdi Benchaib (Author), Frank Plaisant (Author), Dominique Ploin (Author), Yves Gillet (Author), Etienne Javouhey (Author), Olivier Claris (Author), Jean-Charles Picaud (Author), Jean-Sebastien Casalegno (Author), Marine Butin (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early Adjuvant Medication With the mTOR Inhibitor Sirolimus in a Preterm Neonate With Compressive Cystic Lymphatic Malformation
by: Marion Honnorat, et al.
Published: (2020) -
Transcatheter closure of patent ductus arteriosus in preterm infants: results from a single-center cohort
by: Marion Honnorat, et al.
Published: (2023) -
Assessing Behavioral Disorders with SDQ in Very Preterm Children at 5 Years of Age in LIFT Cohort
by: Marine Robert de Saint Vincent, et al.
Published: (2023) -
OP-023 Feasibility of short enteral feeding for bronchiolitis to avoid hospitalization
by: Haesebaert Julie, et al.
Published: (2024) -
RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020
by: Elizabeth R. Packnett, et al.
Published: (2022)